These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31920375)

  • 1. lncRNA DGCR5 Up-Regulates TGF-β1, Increases Cancer Cell Stemness and Predicts Survival of Prostate Cancer Patients.
    Li B; Guo Z; Liang Q; Zhou H; Luo Y; He S; Lin Z
    Cancer Manag Res; 2019; 11():10657-10663. PubMed ID: 31920375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA NBR2 Regulates Cancer Cell Stemness and Predicts Survival in Non-small Cell Cancer Patients by Downregulating TGF-β1.
    Huang J; Yu Q; Zhang J; Lu W; Liu Q; Chu Y; Zhou Y; Tu R; Zhou H; Wang Q
    Curr Pharm Biotechnol; 2023; 24(8):1059-1069. PubMed ID: 35909269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA WT1-AS over-expression inhibits non-small cell lung cancer cell stemness by down-regulating TGF-β1.
    Jiang X; Wang J; Fang L
    BMC Pulm Med; 2020 Apr; 20(1):113. PubMed ID: 32349718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. lncRNA DGCR5 inhibits the proliferation of colorectal cancer cells by downregulating miR-21.
    Huang H; Yang X; Chen J; Fu J; Chen C; Wen J; Mo Q
    Oncol Lett; 2019 Sep; 18(3):3331-3336. PubMed ID: 31452812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA DGCR5 promotes non-small cell lung cancer progression via sponging miR-218-5p.
    Wang J; Shu HZ; Xu CY; Guo SG
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9947-9954. PubMed ID: 31799664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress and assessment of lncRNA DGCR5 in malignant phenotype and immune infiltration of human cancers.
    Xue C; Chen C; Gu X; Li L
    Am J Cancer Res; 2021; 11(1):1-13. PubMed ID: 33520356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. lncRNA DGCR5 acts as a tumor suppressor in papillary thyroid carcinoma via sequestering miR-2861.
    Chen F; Yin S; Zhu J; Liu P; Yang C; Feng Z; Deng Z
    Exp Ther Med; 2019 Jan; 17(1):895-900. PubMed ID: 30651878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA HAND2-AS1 inhibits non-small cell lung cancer migration, invasion and maintains cell stemness through the interactions with TGF-β1.
    Miao F; Chen J; Shi M; Song Y; Chen Z; Pang L
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30509963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LINK-A lncRNA is upregulated in osteosarcoma and regulates migration, invasion and stemness of osteosarcoma cells.
    Kong Y; Nie Z; Guo H; Ma C
    Oncol Lett; 2020 Apr; 19(4):2832-2838. PubMed ID: 32218837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA CASC11 promotes TGF-β1, increases cancer cell stemness and predicts postoperative survival in small cell lung cancer.
    Fu Y; Zhang P; Nan H; Lu Y; Zhao J; Yang M; Song Q
    Gene; 2019 Jul; 704():91-96. PubMed ID: 30965130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA DGCR5 regulates the non-small cell lung cancer cell growth, migration, and invasion through regulating miR-211-5p/EPHB6 axis.
    Kang M; Shi J; Li B; Luo M; Xu S; Liu X
    Biofactors; 2019 Sep; 45(5):788-794. PubMed ID: 31241800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of lncRNA DGCR5 correlates with better prognosis and inhibits bladder cancer progression via transcriptionally facilitating P21 expression.
    Fang C; He W; Xu T; Dai J; Xu L; Sun F
    J Cell Physiol; 2019 May; 234(5):6254-6262. PubMed ID: 30238982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA RPSAP52 Upregulates TGF-β1 to Increase Cancer Cell Stemness and Predict Postoperative Survival in Glioblastoma.
    Wang S; Guo X; Lv W; Li Y; Zhang L; Dong C; Zhang J; Cheng G
    Cancer Manag Res; 2020; 12():2541-2547. PubMed ID: 32368136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DGCR5 is activated by PAX5 and promotes pancreatic cancer via targeting miR-3163/TOP2A and activating Wnt/β-catenin pathway.
    Liu SL; Cai C; Yang ZY; Wu ZY; Wu XS; Wang XF; Dong P; Gong W
    Int J Biol Sci; 2021; 17(2):498-513. PubMed ID: 33613108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA DGCR5 contributes to CSC-like properties via modulating miR-330-5p/CD44 in NSCLC.
    Wang R; Dong HX; Zeng J; Pan J; Jin XY
    J Cell Physiol; 2018 Sep; 233(9):7447-7456. PubMed ID: 29663359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing lncRNA-DGCR5 increased trophoblast cell migration, invasion and tube formation, and inhibited cell apoptosis via targeting miR-454-3p/GADD45A axis.
    Yang Y; Shang H
    Mol Cell Biochem; 2021 Sep; 476(9):3407-3421. PubMed ID: 33973132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. lncRNA DGCR 5/miR‑27a‑3p/BNIP3 promotes cell apoptosis in pancreatic cancer by regulating the p38 MAPK pathway.
    Li X; Zhou S; Fan T; Feng X
    Int J Mol Med; 2020 Aug; 46(2):729-739. PubMed ID: 32626951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-Regulation of LncRNA DGCR5 Correlates with Poor Prognosis in Hepatocellular Carcinoma.
    Huang R; Wang X; Zhang W; Zhangyuan G; Jin K; Yu W; Xie Y; Xu X; Wang H; Sun B
    Cell Physiol Biochem; 2016; 40(3-4):707-715. PubMed ID: 27898409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA DGCR5 suppresses gastric cancer progression by acting as a competing endogenous RNA of PTEN and BTG1.
    Xu Y; Zhang G; Zou C; Gong Z; Wang S; Liu J; Ma G; Liu X; Zhang W; Jiang P
    J Cell Physiol; 2019 Jul; 234(7):11999-12010. PubMed ID: 30515803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polydatin protects H9c2 cells from hypoxia-induced injury via up-regulating long non-coding RNA DGCR5.
    Dai J; Ma J; Liao Y; Luo X; Chen G
    Braz J Med Biol Res; 2019; 52(12):e8834. PubMed ID: 31826181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.